Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes.

While all three categories were associated with decreased risk when compared to patients with no evidence of TMD, much of this variation was accounted for by tumor stage, with only angiogenic and tumor mass dormancy still marginally significant after correction ( Figure 7B and Supplementary Figures 37 – 41 ).

also in 26,082 other papers